508 related articles for article (PubMed ID: 25289647)
1. Functions of FUS/TLS from DNA repair to stress response: implications for ALS.
Sama RR; Ward CL; Bosco DA
ASN Neuro; 2014 Jun; 6(4):. PubMed ID: 25289647
[TBL] [Abstract][Full Text] [Related]
2. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
Ratti A; Buratti E
J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.
Lagier-Tourenne C; Polymenidou M; Cleveland DW
Hum Mol Genet; 2010 Apr; 19(R1):R46-64. PubMed ID: 20400460
[TBL] [Abstract][Full Text] [Related]
4. Fused in sarcoma/translocated in liposarcoma: a multifunctional DNA/RNA binding protein.
Yang S; Warraich ST; Nicholson GA; Blair IP
Int J Biochem Cell Biol; 2010 Sep; 42(9):1408-11. PubMed ID: 20541619
[TBL] [Abstract][Full Text] [Related]
5. Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations.
Kino Y; Washizu C; Aquilanti E; Okuno M; Kurosawa M; Yamada M; Doi H; Nukina N
Nucleic Acids Res; 2011 Apr; 39(7):2781-98. PubMed ID: 21109527
[TBL] [Abstract][Full Text] [Related]
6. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS.
Ito D; Seki M; Tsunoda Y; Uchiyama H; Suzuki N
Ann Neurol; 2011 Jan; 69(1):152-62. PubMed ID: 21280085
[TBL] [Abstract][Full Text] [Related]
7. The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for
Tischbein M; Baron DM; Lin YC; Gall KV; Landers JE; Fallini C; Bosco DA
J Biol Chem; 2019 Jun; 294(26):10194-10210. PubMed ID: 31092554
[TBL] [Abstract][Full Text] [Related]
8. TAR DNA binding protein-43 and fused in sarcoma/translocated in liposarcoma protein in two neurodegenerative diseases.
Wang XN; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):286-92. PubMed ID: 22776664
[TBL] [Abstract][Full Text] [Related]
9. TDP-43/FUS in motor neuron disease: Complexity and challenges.
Guerrero EN; Wang H; Mitra J; Hegde PM; Stowell SE; Liachko NF; Kraemer BC; Garruto RM; Rao KS; Hegde ML
Prog Neurobiol; 2016; 145-146():78-97. PubMed ID: 27693252
[TBL] [Abstract][Full Text] [Related]
10. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS.
Kamelgarn M; Chen J; Kuang L; Arenas A; Zhai J; Zhu H; Gal J
Biochim Biophys Acta; 2016 Oct; 1862(10):2004-14. PubMed ID: 27460707
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis.
Shang Y; Huang EJ
Brain Res; 2016 Sep; 1647():65-78. PubMed ID: 27033831
[TBL] [Abstract][Full Text] [Related]
13. Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration.
Dormann D; Haass C
Mol Cell Neurosci; 2013 Sep; 56():475-86. PubMed ID: 23557964
[TBL] [Abstract][Full Text] [Related]
14. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs.
Lagier-Tourenne C; Polymenidou M; Hutt KR; Vu AQ; Baughn M; Huelga SC; Clutario KM; Ling SC; Liang TY; Mazur C; Wancewicz E; Kim AS; Watt A; Freier S; Hicks GG; Donohue JP; Shiue L; Bennett CF; Ravits J; Cleveland DW; Yeo GW
Nat Neurosci; 2012 Nov; 15(11):1488-97. PubMed ID: 23023293
[TBL] [Abstract][Full Text] [Related]
15. FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.
Suzuki N; Kato S; Kato M; Warita H; Mizuno H; Kato M; Shimakura N; Akiyama H; Kobayashi Z; Konno H; Aoki M
J Neuropathol Exp Neurol; 2012 Sep; 71(9):779-88. PubMed ID: 22878663
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of amyotrophic lateral sclerosis.
Liscic RM; Breljak D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):370-2. PubMed ID: 20655970
[TBL] [Abstract][Full Text] [Related]
17. [The FUS protein: Physiological functions and a role in amyotrophic lateral sclerosis].
Efimova AD; Ovchinnikov RK; Roman AY; Maltsev AV; Grigoriev VV; Kovrazhkina EA; Skvortsova VI
Mol Biol (Mosk); 2017; 51(3):387-399. PubMed ID: 28707655
[TBL] [Abstract][Full Text] [Related]
18. Amyotrophic lateral sclerosis-linked FUS/TLS alters stress granule assembly and dynamics.
Baron DM; Kaushansky LJ; Ward CL; Sama RR; Chian RJ; Boggio KJ; Quaresma AJ; Nickerson JA; Bosco DA
Mol Neurodegener; 2013 Aug; 8():30. PubMed ID: 24090136
[TBL] [Abstract][Full Text] [Related]
19. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma.
Bentmann E; Haass C; Dormann D
FEBS J; 2013 Sep; 280(18):4348-70. PubMed ID: 23587065
[TBL] [Abstract][Full Text] [Related]
20. Altered mRNP granule dynamics in FTLD pathogenesis.
Bowden HA; Dormann D
J Neurochem; 2016 Aug; 138 Suppl 1():112-33. PubMed ID: 26938019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
